DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $675,824 | -32.3% | 2,724 | -34.5% | 0.14% | -22.7% |
| Q2 2023 | $998,160 | -3.7% | 4,159 | +1.1% | 0.18% | +17.3% |
| Q1 2023 | $1,036,641 | +17.7% | 4,113 | +24.0% | 0.15% | +8.7% |
| Q4 2022 | $880,398 | +19.9% | 3,317 | +16.6% | 0.14% | +11.3% |
| Q3 2022 | $734,000 | -88.8% | 2,845 | -89.0% | 0.12% | -86.7% |
| Q2 2022 | $6,573,000 | -20.0% | 25,928 | -7.4% | 0.93% | -15.1% |
| Q1 2022 | $8,216,000 | +669.3% | 28,012 | +762.7% | 1.10% | +759.4% |
| Q4 2021 | $1,068,000 | +81.6% | 3,247 | +67.9% | 0.13% | +68.4% |
| Q3 2021 | $588,000 | +24.3% | 1,934 | +9.7% | 0.08% | +33.3% |
| Q2 2021 | $473,000 | -43.8% | 1,763 | -52.8% | 0.06% | -43.0% |
| Q1 2021 | $841,000 | -91.4% | 3,737 | -91.5% | 0.10% | -92.1% |
| Q4 2020 | $9,813,000 | -76.9% | 44,177 | -77.6% | 1.26% | -81.5% |
| Q3 2020 | $42,471,000 | +32.2% | 197,237 | +8.6% | 6.84% | -7.3% |
| Q2 2020 | $32,116,000 | +70.9% | 181,620 | +33.8% | 7.37% | +3.7% |
| Q1 2020 | $18,788,000 | -12.6% | 135,741 | -3.0% | 7.11% | -4.9% |
| Q4 2019 | $21,485,000 | -68.8% | 139,984 | -70.7% | 7.48% | -12.0% |
| Q3 2019 | $68,890,000 | -28.9% | 476,984 | -29.7% | 8.49% | -0.9% |
| Q2 2019 | $96,930,000 | +472.0% | 678,209 | +428.3% | 8.57% | -6.7% |
| Q1 2019 | $16,947,000 | -1.2% | 128,368 | -22.8% | 9.18% | +17.1% |
| Q4 2018 | $17,156,000 | – | 166,365 | – | 7.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |